Columbia bioengineers used an electromechanical “workout” program to turn human stem cells into adult-like heart tissue in just four weeks.
Sitting around for one to two hours at a time without moving increases the risk of death, finds a new study.
Higher up-front costs for intensive blood pressure control are outweighed by long-term cardiac benefits, shows study.
A new clinical trial will determine if the drug apixaban can prevent recurrent strokes in people with atrial cardiopathy.
Aspirin does not increase the risk of hospitalization or death in patients taking ACE inhibitors or ARBs for heart failure, Columbia researchers have found.
Using a noninvasive test developed at Columbia, older TAVR patients with an unusual heart failure pattern were found to have cardiac amyloidosis.